Basilea Pharmaceutica AG Cash Flow Statement

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	40.24	77.59	10.45	12.15	-6.83
Depreciation & Amortization	3.71	3.53	3.18	2.7	2.25
Other Amortization	0.59	0.6	1.74	0.66	1.3
Loss (Gain) From Sale of Assets	-	1.02	-	-	-0.07
Stock-Based Compensation	5.24	5.07	4.76	3.6	4.32
Other Operating Activities	3.55	-19.75	-1.57	-0.32	0.39
Change in Accounts Receivable	-4.62	19.03	5.23	-8.24	-16.25
Change in Inventory	10.05	-5.2	-2.17	-1.46	-1.59
Change in Accounts Payable	3.57	5.64	5.66	-10.43	-2.54
Change in Unearned Revenue	-1.97	2.31	-1.23	-1.23	-2.56
Change in Other Net Operating Assets	1.73	-15.48	-11.8	9.64	-10.45
Operating Cash Flow	62.09	74.36	14.25	7.06	-32.02
Operating Cash Flow Growth	-16.50%	422.03%	101.89%	-	-
Capital Expenditures	-2.62	-1.71	-0.81	-3.14	-0.58
Sale of Property, Plant & Equipment	-	-	-	-	0.02
Divestitures	-	0.78	-	-	-1.6
Sale (Purchase) of Intangibles	-0.24	-0.08	-0.22	-0.17	-0.28
Investment in Securities	-	-	-	94.95	6.02
Other Investing Activities	-	-	-	0	-
Investing Cash Flow	-2.86	-1.01	-1.03	91.65	3.58
Long-Term Debt Issued	-	-	-	73.88	-
Long-Term Debt Repaid	-	-15.6	-59.31	-	-
Net Debt Issued (Repaid)	-	-15.6	-59.31	73.88	-
Issuance of Common Stock	0.69	2.46	2.48	4.43	44.11
Repurchase of Common Stock	-	-	-	-	-4.25
Other Financing Activities	-22.12	-0.02	-0.47	-123.55	-23.21
Financing Cash Flow	-21.43	-13.16	-57.31	-45.25	16.64
Foreign Exchange Rate Adjustments	-0.03	0.05	-0.15	0.16	0.5
Miscellaneous Cash Flow Adjustments	-	-	-	-	0
Net Cash Flow	37.78	60.24	-44.25	53.61	-11.3
Free Cash Flow	59.47	72.65	13.43	3.92	-32.6
Free Cash Flow Growth	-18.14%	440.89%	242.83%	-	-
Free Cash Flow Margin	25.59%	34.84%	8.52%	2.65%	-22.01%
Free Cash Flow Per Share	4.35	5.24	1.11	0.33	-2.79
Cash Interest Paid	3.04	3.73	9.76	6.33	7.07
Cash Income Tax Paid	-	-	0.01	0	0.04
Levered Free Cash Flow	49.16	48.68	8.51	-2.45	-25.21
Unlevered Free Cash Flow	50.67	50.8	14.07	3.25	-21.22
Change in Working Capital	8.77	6.29	-4.32	-11.72	-33.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.